Impact of Targeted Molecular Imaging with 18F-PSMA-1007 and 68Ga-PSMA-11 PET/CT in Multimodal Evaluation of Local Recurrence of Prostate Cancer

被引：0
|
作者：
Dronka, L. [1 ,2 ]
Radzina, M. [1 ,2 ]
Tirane, M. [1 ,2 ]
Zemniece, L. [1 ]
Kalnina, M. [1 ,3 ]
Roznere, L. [2 ,3 ]
Briede, I. [4 ]
Lietuvietis, V. [5 ]
Freimanis, A. [5 ]
Vjaters, E. [6 ]
机构：
[1] Pauls Stradins Clin Univ Hosp, Inst Radiol, Riga, Latvia
[2] Riga Stradins Univ, Radiol Res Lab, Riga, Latvia
[3] Riga Stradins Univ, Nucl Med Clin, Riga, Latvia
[4] Pauls Stradins Clin Univ Hosp, Ctr Patol, Riga, Latvia
[5] Riga East Univ Hosp, Ctr Urol, Riga, Latvia
[6] Pauls Stradins Clin Univ Hosp, Ctr Urol, Riga, Latvia
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2020年 / 47卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-338
引用
收藏
页码：S173 / S174
页数：2
相关论文
共 50 条
  • [1] Serial 18F-PSMA-1007 PET/CT imaging: A comparative study with 68Ga-PSMA-11
    Sharma, P.
    Watts, A.
    Singh, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S114 - S115
  • [2] Comparative analysis of 68Ga-PSMA-11 and 18F-PSMA-1007 in prostate cancer restaging PET/CT: differences and similarities
    Lavelli, V.
    Ferrari, C.
    Pisani, A. R.
    Battisti, C.
    Palumbo, C.
    Merenda, N. C.
    Rubini, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S535 - S536
  • [3] Advantage of 18F-PSMA-1007 over 68Ga-PSMA-11 PET imaging for differentiation of local recurrence vs. urinary tracer excretion
    Rahbar, Kambiz
    Weckesser, Matthias
    Ahmadzadehfar, Hojjat
    Schaefers, Michael
    Stegger, Lars
    Boegemann, Martin
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (06) : 1076 - 1077
  • [4] A PROSPECTIVE INTRA-INDIVIDUAL BLINDED COMPARISON OF 18F-PSMA-1007 AND 68GA-PSMA-11 PET/CT IMAGING IN PATIENTS WITH CONFIRMED PROSTATE CANCER
    Debowski, M.
    Gulhane, B.
    Ramsay, S. C.
    Thomas, P. A.
    Garcia, P.
    Latter, M.
    Tapper, S.
    Pattison, D. A.
    INTERNAL MEDICINE JOURNAL, 2019, 49 : 27 - 27
  • [5] Advantage of 18F-PSMA-1007 over 68Ga-PSMA-11 PET imaging for differentiation of local recurrence vs. urinary tracer excretion
    Kambiz Rahbar
    Matthias Weckesser
    Hojjat Ahmadzadehfar
    Michael Schäfers
    Lars Stegger
    Martin Bögemann
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 1076 - 1077
  • [6] Impact of 18F-PSMA-1007 Ligand PET/CT in Multimodal Imaging of Recurrent Prostate Cancer
    Dronka, L.
    Radzina, M.
    Tirane, M.
    Zemniece, L.
    Kalnina, M.
    Roznere, L.
    Lietuvietis, V.
    Freimanis, A.
    Vjaters, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S27 - S28
  • [7] Gross tumor volume delineation in primary prostate cancer on 18F-PSMA-1007 PET/MRI and 68Ga-PSMA-11 PET/MRI
    Yan-Nan Zhang
    Zhen-Guo Lu
    Shuai-Dong Wang
    Xin Lu
    Lei-Lei Zhu
    Xu Yang
    Li-Ping Fu
    Jun Zhao
    Hai-Feng Wang
    Zuo-Lin Xiang
    Cancer Imaging, 22
  • [8] Gross tumor volume delineation in primary prostate cancer on 18F-PSMA-1007 PET/MRI and 68Ga-PSMA-11 PET/MRI
    Zhang, Yan-Nan
    Lu, Zhen-Guo
    Wang, Shuai-Dong
    Lu, Xin
    Zhu, Lei-Lei
    Yang, Xu
    Fu, Li-Ping
    Zhao, Jun
    Wang, Hai-Feng
    Xiang, Zuo-Lin
    CANCER IMAGING, 2022, 22 (01)
  • [9] Comparison of 18F-PSMA-1007 PET/CT With 68Ga-PSMA-11 PET/CT for Initial Staging in Intermediate- and High-Risk Prostate Cancer
    Chandekar, Kunal Ramesh
    Singh, Harmandeep
    Kumar, Rajender
    Kumar, Santosh
    Kakkar, Nandita
    Mittal, Bhagwant Rai
    Singh, Shrawan Kumar
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (01) : E1 - E8
  • [10] Preliminary comparative study between 18F-PSMA-1007 and 68Ga-PSMA-11 PET/CT in patients with prostate cancer biodistribution and tumor detection
    Chen, Sirong
    Wong, Yuet Hung
    Tsoi, Tung Tung
    Leung, Yim Lung
    Cheng, Kam Chau
    Wong, Ka Nin
    Cheung, William
    Wu, Kwan Kit
    Ho, Chi-Lai
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
12345